In the study, conducted on rats, this compound reduced glucose production by liver cells that were growing in culture and shifted the liver gene expression away from a diseased state in the rats with diabetes. Sulforaphane reversed the disease signature in the livers from diabetic animals and cut exaggerated glucose production and glucose intolerance by a magnitude similar to that of metformin, said Annika Axelsson from the Lund University in Sweden.
Read More...